These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 7755386

  • 1. [Late phase II trial of high-dose l-leucovorin and 5-fluorouracil in advanced colorectal carcinoma. l-Leucovorin and 5-FU Study Group (Japan Eastern Group)].
    Yoshino M, Ota K, Kurihara M, Akazawa S, Tominaga T, Sasaki T, Konishi T, Kodaira S, Kumai K, Sugano K.
    Gan To Kagaku Ryoho; 1995 May; 22(6):785-92. PubMed ID: 7755386
    [Abstract] [Full Text] [Related]

  • 2. [A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
    Konishi K, Yabushita K, Taguchi T, Ota J, Takashima S, Abe T, Kikkawa N, Yasutomi M, Sowa M, Maehara Y.
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):925-32. PubMed ID: 7793998
    [Abstract] [Full Text] [Related]

  • 3. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
    Nobile MT, Barzacch MC, Sanguineti O, Chiara S, Gozza A, Vincenti M, Lavarello A, Cognein P, Lionetto R, Percivale PL, Bertoglio S, Murolo C, Esposito M, Vannozzi MO, Rosso R.
    Anticancer Res; 1998 Jun; 18(1B):517-21. PubMed ID: 9568171
    [Abstract] [Full Text] [Related]

  • 4. [Early phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group].
    Sugano K, Ota K, Taguchi T, Ogawa N, Kurihara M, Akazawa S, Ogawa M, Tominaga T, Sasaki T, Konishi T.
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):627-37. PubMed ID: 7717714
    [Abstract] [Full Text] [Related]

  • 5. [High-dose leucovorin and 5-fluorouracil in advanced gastric and colorectal cancer. High-Dose Leucovorin and 5-FU Study Group].
    Sasaki T, Ota K, Sakata Y, Matsuoka T, Wakui A, Akazawa S, Ogawa M, Mukaiyama T, Yoshino M, Sakai Y.
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2361-8. PubMed ID: 2260872
    [Abstract] [Full Text] [Related]

  • 6. [A cooperative late phase II trial of l-leucovorin and 5-fluorouracil in the treatment of advanced gastric cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
    Takeda S, Taguchi T, Ohta J, Kurihara M, Abe T, Ohtani T, Yonemura Y, Ohno T, Hirabayashi N, Nakano S.
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):903-10. PubMed ID: 7793996
    [Abstract] [Full Text] [Related]

  • 7. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević A.
    Srp Arh Celok Lek; 1998 Jun; 126(9-10):355-61. PubMed ID: 9863407
    [Abstract] [Full Text] [Related]

  • 8. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Beerblock K, Rinaldi Y, André T, Louvet C, Raymond E, Tournigand C, Carola E, Favre R, de Gramont A, Krulik M.
    Cancer; 1997 Mar 15; 79(6):1100-5. PubMed ID: 9070486
    [Abstract] [Full Text] [Related]

  • 9. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E, Beuzeboc P, Deffontaines D, Diéras V, Dorval T, Jouve M, Palangie T, Scholl S, Pouillart P.
    J Infus Chemother; 1996 Mar 15; 6(3):149-51. PubMed ID: 9229328
    [Abstract] [Full Text] [Related]

  • 10. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N.
    Cancer; 1996 Sep 15; 78(6):1300-7. PubMed ID: 8826954
    [Abstract] [Full Text] [Related]

  • 11. Treatment of advanced colorectal adenocarcinoma with weekly high-dose l-leucovorin and 5-fluorouracil.
    Nozue M, Isaka N, Maruyama T, Kawamoto T, Seino KI, Tanagichi H, Fukao K.
    Oncol Rep; 2002 Sep 15; 9(1):93-6. PubMed ID: 11748463
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of leucovorin and 5-fluorouracil].
    Sasaki T.
    Gan To Kagaku Ryoho; 1995 Jul 15; 22(8):1001-8. PubMed ID: 7611750
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H.
    Jpn J Clin Oncol; 2007 Sep 15; 37(9):686-91. PubMed ID: 17720736
    [Abstract] [Full Text] [Related]

  • 14. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
    Aranda E, Cervantes A, Carrato A, Antón-Torres A, Massutí T, Fernández-Martos C, Díaz-Rubio E.
    J Infus Chemother; 1996 Sep 15; 6(3):118-22. PubMed ID: 9229321
    [Abstract] [Full Text] [Related]

  • 15. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
    Link K, Happich K, Schirner I, Jüngert B, Brückl V, Männlein G, Brückl WM, Merkel S, Göhl J, Hohenberger W, Hahn EG, Wein A.
    Anticancer Res; 2004 Sep 15; 24(1):385-91. PubMed ID: 15015625
    [Abstract] [Full Text] [Related]

  • 16. [High-dose leucovorin and 5-FU].
    Sasaki T.
    Gan To Kagaku Ryoho; 1992 Jul 15; 19(7):954-62. PubMed ID: 1626951
    [Abstract] [Full Text] [Related]

  • 17. Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancer.
    Tsavaris N, Kosmas C, Gennatas K, Vadiaka M, Paliaros P, Dimitrakopoulos A, Diamantis T, Tsipras H, Papastratis G.
    Med Sci Monit; 2002 Sep 15; 8(9):PI65-9. PubMed ID: 12218954
    [Abstract] [Full Text] [Related]

  • 18. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S.
    J Clin Oncol; 2004 Dec 01; 22(23):4753-61. PubMed ID: 15570076
    [Abstract] [Full Text] [Related]

  • 19. High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer.
    Loeffler TM, Hausamen TU.
    J Infus Chemother; 1996 Dec 01; 6(3):137-40. PubMed ID: 9229325
    [Abstract] [Full Text] [Related]

  • 20. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K.
    Jpn J Clin Oncol; 2006 Apr 01; 36(4):218-23. PubMed ID: 16684860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.